Results

Total Results: 1,185 records

Showing results for "author year description".

101. Evidence Report No. 222, Data Linkage Strategies To Advance Youth Suicide Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research.pdf
     October 01, 2016 - § See Table 1 for the full PICOTS description. … Summary of intervention characteristics Program or Study Name (If Applicable) Author, Year Intervention … Summary of intervention characteristics (continued) Program or Study Name (if applicable) Author, Year … Summary of intervention characteristics (continued) Program or Study Name (if applicable) Author, Year … x 6 Year Data Collection Started 3 date (YYYY) x 6 Year Data Collection Stopped 3 date (YYYY

102. Evidence Map on Home and Community Based Services (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-map-hcbs-protocol.pdf
     July 27, 2023 - We plan to include studies published after the year 2000 and studies conducted in the United States. … Registrar of Controlled Trials, Ovid® Cochrane Database of Systematic Reviews, and Scopus® from the year … We will limit the literature to studies published in English and published after the year 2000. … Information Management We will develop a standardized data extraction form to extract study characteristics (author … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

103. Disposition of Comments for Evidence Report 224 Omega-3 Fatty Acids (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_disposition-comments.pdf
     October 12, 2016 - Perhaps a brief description of the methodology to quantitate omega-3 levels for the included studies … have added it to the description of the findings of this study. … Author name “van Goor”-this study is presented in the tables twice, pg 132 & pg 133-134 Pg 170 line … We have made every effort to be transparent in our description of our methods and decisions. … Customarily, update searches commence with the publication year one year prior to the latest search

104. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidence Base (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-dispositIon-comments-2022.pdf
     January 01, 2022 - Published Online: October 24, 2022 2 Peer Reviewer, Technical Expert, and Public Comments and Author … Figure 7-consider footnoting the Year 2021 since the data for it are only for part of the year. … First, the title should probably indicate that the unit of description (i.e. row) here is treatment … Commentator & Affiliation Section Comment Response Peer Reviewer #5 General The report is a description … from a total of 427) the question is -are there studies that are close to completion where waiting a year

105. Glaucoma-Treatment Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-treatment_research-protocol.pdf
     November 16, 2010 - Description of the condition Glaucoma is a leading cause of visual impairment and blindness worldwide … A detailed description of Food and Drug Administration (FDA) approval status, indications, and warnings … Death Description of Key Question 5 Key Question 5 explores the association of 1) lowering intraocular … Timing Outcomes will be assessed at 1 year of follow-up and at annual intervals thereafter. … Comparison of treatment outcomes within race: 10-year results. Ophthalmology 2004;111:651-64.

106. Microsoft Word - 3-DKE274__ACEI-ARB-DRI__Comments_Disposition_Table-21_Jan_2011 cyk _2_.docx (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
     October 07, 2011 - Executive Summary There is an incorrect description of the Renin-Angiotensin Aldosterone System ( … The description has been corrected and now matches the main report. … meaningful way (e.g., all the RCTs together, all the observational studies together, and then sorted by year … re-formatted the figures and tables to list RCTs and observational studies together in a group and then by year … Rather than having readers find the original GRADE papers, a very brief description of the relevant

107. Disposition of Comments Report for Biologic and Nonbiologic Systemic Agents and Phottherapy for Treatment of Chronic Plaque Psoriasis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
     November 27, 2012 - Etanercept is 64 shots in the 1st year, adalimumab is 28 shots in the 1st year, and ustekinumab is 5 … shots in the 1st year of therapy. … For example a brief description of each scale chosen, and some reasoning why these scales were chosen … The description of comparisons is provided in the text above the table. 8. … Please include a description of the methodology for the CHAMPION trial Thank you for this comment.

108. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cerebral-palsy-feeding_research-protocol.pdf
     June 12, 2012 - Data suggest that during the first year of life, 57 percent of children with CP have sucking problems … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, population and intervention descriptions, sample size, key outcomes, and study … Prevalence of cerebral palsy among ten-year-old children in metropolitan Atlanta, 1985 through 1987. … A priori' methods of assessment should be provided (e.g., for effectiveness studies if the author(s

109. Disposition of Comments for CER 157 Appendicitis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_disposition-comments.pdf
     December 14, 2015 - Peer Reviewer #5 Introduction In your description of the clinical symptoms and signs suggestive … We think that year of publication cut-offs are not appropriate because technology diffusion happens … Did you notice any differences based on publication year? … Please note that 1956 was not a cut-off year chosen by us, it is simply a reflection of the indexing … We have attempted to capture the evolution of the technology by examining subgroups by year of study

110. Disposition of Comments Report for The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-197-fractional-exhaled-nitric-oxide-disposition-comments.pdf
     December 20, 2017 - The first is a paper that was presented in Germany the same day as ref 6, but published the next year … with the diagnostic meta- analysis estimates for sensitivity, specificity, likelihood ratios and a description … The tables in the appendix follow a standard EPC format (search strategy, excluded studies, description … I did not find the an explicit description of the intended audience No other concerns.

111. Disposition of Comments for Technical Brief 18 Public Reporting of Cost Measures in Health (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-cost-measures_disposition-comments.pdf
     March 05, 2015 - The guiding questions cover the following: a description of the measures of cost that have been publicly … Based on that description, the Maine website also sounded to me like the website was giving data on … Recommend more nuanced description of next steps needed to further validate, rather than only how the … I did not see any description of other grading systems? … Reviewer#4 General Comments This is a very nicely executed scan and description of public reporting

112. Disposition of Comments_Comparative Effectiveness Review No. 253: Maternal and Child Outcomes Associated With the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/maternal-child-outcomes-wic-disposition-comments.pdf
     April 19, 2022 - outcomes-nutrition/research Published Online: April 19, 2022 2 Summary of Peer Reviewer Comments and Author … products/outcomes-nutrition/research Published Online: April 19, 2022 3 Public Comments and Author … Association (NWA) Introduction The introduction section similarly is accurate and detailed in its description … Thank you National WIC Association (NWA) Methods Include a brief description on the funding sources … We have edited as suggested National WIC Association (NWA) Discussion WIC’s funding description

113. Disposition of Comments Report for Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating Musculoskeletal Complaints in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_disposition-comments.pdf
     March 07, 2012 - Clearly newborns barely make immunoglobulin whereas 18 year olds have adult levels. … None of the studies looked specifically at children with joint swelling; we added this to the description … We have reworded the outcome description for KQ5. … Outcome of high titer ANA positivity in individuals w/o connective tissue disease: 10 year followup … Outcome of high titer ANA positivity in individuals w/o connective tissue disease: 10 year followup

114. Disposition of Comments for Evidence Report 220 Health Information Exchange (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-information-exchange-disposition-160504.pdf
     December 15, 2015 - TEP Reviewer #5 Introduction A very clear description of the current state of the literature and its … Peer Reviewer #8 Results Page 29 line 12: out in the year as this will not stad the "test of time" … However the description of push system was not clear to me. c. … For example, a dump of all filled prescriptions organized by dispensing data for the last year will … The 5-year survival of all start-up businesses is about 10%.

115. Disposition of Comments for Technical Brief 31 Mobile Applications for Self-Management of Diabetes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tech-brief-31-mobile-applications-self-mgmt-disposition-comments.pdf
     May 08, 2018 - I think the key concept for all reviews is transparency and realistic description of the results as … Key Informant #4 General Page 10, description of mHealth evaluation, this section is much too brief … Peer Reviewer #1 Findings The Description of Apps section is useful. … Unfortunately, the app names did not fit into this graph, but we put the citation by each (Author, … Year) so readers could trace the citation across different sections of the report.

116. Disposition of Comments for Treatment of Glaucoma: Comparative Effectiveness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_disposition-comments.pdf
     April 01, 2012 - This should be done using Corporate Author and keyword searches. … The Corporate Author search alone is not reliable. … Three-year follow-up of the tube versus trabeculectomy study. … Also, as the author points out, there is no formal economic analysis comparing trabeculectomy, laser … A description of the studies included precedes this paragraph, but there is no description or metaanalysis

117. Technical Brief: Evaluation of Suspicious Skin Lesions Using Non-Invasive Diagnostic Techniques | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/skin-lesions-evaluation/research-protocol
     August 23, 2010 - These two types of nonmelanomatous (NMSC) lesions, responsible for more than 800,000 cases per year, … 4 One study found that “melanoma incidence rates had doubled in all socioeconomic groups over a 10-year … period”. 5 Another study found that melanoma incidence rates have increased by 3% per year in white … From qualified studies, we will extract data on the citation (first author name, journal and year of

118. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/administrative-data-validity_research.pdf
     January 01, 2007 - Only about 5% of SCD cases survive.4 SCD results in 300,000-456,000 deaths per year, or about 12-19% … SCD is 1.8 per 1000 in the general US population,9 which mirrors the rate of about 2 per 1000 per year … SCD/VA ICD-9 diagnosis codes ICD-9 Code Description 427.1 Paroxysmal Ventricular Tachycardia; Ventricular

119. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/upenn-final-report-2005-certs-ce-supplement.pdf
     January 01, 2005 - Only about 5% of SCD cases survive.4 SCD results in 300,000-456,000 deaths per year, or about 12-19% … SCD is 1.8 per 1000 in the general US population,9 which mirrors the rate of about 2 per 1000 per year … SCD/VA ICD-9 diagnosis codes ICD-9 Code Description 427.1 Paroxysmal Ventricular Tachycardia; Ventricular

120. Registry of Patient Registries (RoPR): Project Overview (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries_research-2012-3_0.pdf
     January 01, 2012 - ...........................4 Effective Health Care Program Research Report Number 40 v Author … Registry Description—identification and description information. 2.